EMA CT Regulation and EU Portal
CT Quality in the Digital Health Era
Risk-based Monitoring and RBQM
The break down sessions were not very interesting, also asking the presenters to organize them was not ideal as they did not seem prepared. Tables should be mixed and names assigned to facilitate ...
Visitor
This is the third time I participate and it is always an interesting opportunity for learning and keeping updated in GCP news and specially on Inspectors expectations. Very good
Visitor
The 3rd Annual Clinical Trials and Quality Compiance Conference covers a deep look inside the implementation and requirements for risk-based quality management 2 years after ICH E6 R2 Addendum release. This conference includes special features like Inspector's view, Round-table discussion, 5 hours of practical case studies, great speaker panel and the agenda created by senior executives in the Medical Devices and Diagnostics industry.
This is the third time I participate and it is always an interesting opportunity for learning and keeping updated in GCP news and specially on Inspectors expectations. Very good
The break down sessions were not very interesting, also asking the presenters to organize them was not ideal as they did not seem prepared. Tables should be mixed and names assigned to facilitate the interactions. People should be given 5 min after each "mixing" for example after breaks to reintroduce themselves during 5 mn (take it from the time of the breaks) - The goal before end of the 1st day, everyone should have a good idea of who is doing what in the audience. Not all presentations were insightful, mostly the ones that showed the tools / strategy used by others, when its too general then it remains at a "bar type" discussion. Would have been good to have more input from the audience, their challenges etc in order to exchange more. Some time was also too devoted about high level discussions such as the future in clinical research. Very low usage of the voting tool, its a shame - seems that the presenter do not know how to integrate them in their presentations yet. ... Show more Show less
The presentations were very theoretical and high level. I was missing best practise sharing how to inplement in daily work and how to get investigatord on board.
Working for a small CRO it was important for me to know and see where the big pharma and CRO's are and what experience they have with QA. It was very insightful. It was too cold, too strong climatisation.
Chairing 1st not good/chaotic (summary not done?). Second day (Matt) much better. it's a pity that the inspector's expectation session was cancelled, I was really interested in that. recommendation: play music before meeting starts and during the breaks...
veryîteractive with interrsting topicd and well organized.
Tool is easy to use and helps to reduce paper and waste
Great opportunity to hear about current hot topics and how companies are addressing them
This event helps me to stay up to date, to see visions and challenges. Thank you.
Chairing 1st not good/chaotic (summary not done?). Second day (Matt) much better. it's a pity that the inspector's expectation session was cancelled, I was really interested in that. recommendation: play music before meeting starts and during the breaks...
Changes to agenda, probably beyond control of the Fleming, but indicates the conference needs to work on its reputation. Presenters should think twice before canceling their presence. Provision of the presentations during the conference would appreciated. Good opportunity to network or meet with new people from different, less known, companies or familiar faces. Thanks for the opportunity to present.
Fleming. connects people who know the answers, bring you the know-how you seek and the opportunities you desire. Go to event website »
Visitor
Visitor
Visitor
Speaker
Speaker
Speaker
Speaker
Visitor
Speaker
Visitor
Speaker
Speaker
Visitor
